Literature DB >> 28975515

Bermuda Triangle: N-terminal pro-B-type natriuretic peptide, stroke, and galectin-3.

Levent Cerit1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28975515     DOI： 10.1007/s11239-017-1564-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  5 in total

1.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

2.  The change in circulating galectin-3 predicts absence of atrial fibrillation after thoracoscopic surgical ablation.

Authors:  Wouter R Berger; Benoît Jagu; Nicoline W E van den Berg; Dean R P P Chan Pin Yin; Jan P van Straalen; Onno J de Boer; Antoine H G Driessen; Jolien Neefs; Sébastien P J Krul; WimJan P van Boven; Allard C van der Wal; Joris R de Groot
Journal:  Europace       Date:  2018-05-01       Impact factor: 5.214

3.  Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation.

Authors:  Duygu Kocyigit; Kadri Murat Gurses; Muhammed Ulvi Yalcin; Hande Canpinar; Ugur Canpolat; Banu Evranos; Hikmet Yorgun; Necla Ozer; Dicle Guc; Kudret Aytemir
Journal:  J Clin Lab Anal       Date:  2017-03-13       Impact factor: 2.352

4.  N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy.

Authors:  Gerald Chi; James L Januzzi; Serge Korjian; Yazan Daaboul; Samuel Z Goldhaber; Adrian F Hernandez; Russell D Hull; Alex Gold; Alexander T Cohen; Robert A Harrington; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

5.  Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.

Authors:  Jordan B King; Peyman N Azadani; Promporn Suksaranjit; Adam P Bress; Daniel M Witt; Frederick T Han; Mihail G Chelu; Michelle A Silver; Joseph Biskupiak; Brent D Wilson; Alan K Morris; Eugene G Kholmovski; Nassir Marrouche
Journal:  J Am Coll Cardiol       Date:  2017-09-12       Impact factor: 24.094
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.